Epilepsies, Myoclonic - 25 Studies Found Recruiting : Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome : Epilepsy : 2016-04-04 : Drug: ataluren Powder formulat Not yet recruiting : Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome : Dravet Syndrome : 2014-12-12 : Drug: Cannabidiol Oral Solution Recruiting : GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome : Epilepsy Dravet Syndrome : 2014-08-21 : Drug: GWP42003-P Other Names: Terminated : Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome : Dravet Syndrome : 2014-07-09 : Drug: Clobazam Other Name: Onfi® Withdrawn : Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome : Dravet Syndrome : 2014-06-02 : Drug: Clobazam Other Name: Onf Completed : Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) : Epilepsy Dravet Syndrome : 2014-03-17 : Drug: GWP42003-P GWP42003-P is Completed : A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1) : Epilepsy Dravet Syndrome : 2014-03-17 : Drug: GWP42003-P Available : Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome : Dravet Syndrome : 2013-11-07 : Drug: Stiripentol Available : Compassionate Use of Stiripentol in Dravet Syndrome : Dravet Syndrome : 2013-04-15 : Drug: Stiripentol Stiripentol 5-50mg/kg/d divided twice or three times a day by mouth Completed : Verapamil as Therapy for Children and Young Adults With Dravet Syndrome : Dravet Syndrome : 2012-05-24 : Drug: Verapamil Verapamil will be prepared as a solution. <<< Previous | Next >>>